Aushon BioSystems Forms Scient

Aushon BioSystems, a provider of microarray products and laboratory services for biomarker discovery, development and analysis, announced the formation of a Scientific Advisory Board consisting North Face Jackets of internationally physicians and scientists at the forefront of applying biomarker technology in clinical drug development.

According to a release, the Board includes:

Johann de Bono, Senior Lecturer and Honorary Consultant in Medical Oncology at the Royal Marsden Hospital and Institute of Cancer Research;

John Heymach, Associate Professor of Thoracic Head/Neck Medical Oncology and Cancer Biology at the University of Texas Anderson Cancer Center;

North Face Jackets North Face Jackets

Gavin MacBeath, Senior Director and the Head of Translational Research, Merrimack Pharmaceuticals;

Gordon Mills, Wiess Distinguished University Chair in Cancer Medicine, Chair of the Department of Systems Biology in the Division of Cancer Medicine, and Co-head of the Kleberg Center for Molecular Markers of the University of Texas Anderson Cancer Center.

"The establishment of our new Scientific Advisory Board with these visionary thought leaders is another significant milestone for Aushon," said Pete Honkanen, President and CEO of Aushon BioSystems. "Not only will the SAB provide Aushon with the critical insights and strategic guidance essential to ensuring that our Breguet Replica leading-edge multiplex immunoassay platform continues to meet today's research needs, but they Breguet Replica will also help us anticipate key future trends and market opportunities, including the use of multiplex protein biomarkers in companion diagnostics."

Aushon BioSystems provides microarray printing technology, biomarker content and multiplex immunoassay development and detection services to pharmaceutical, biotechnology, academic and diagnostic organizations.

Breguet Replica

((Comments on this story may be sent to ))